Gene · 168667
Papers1,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USE-SVI: A reproducible pipeline for sampling, acquiring, and stitching Street View imagery to support urban analytics. | MethodsX | 2026 | 41567358 | PubTator, text mining | PubMed |
| Reevaluating CV2/CRMP5 positivity as a marker of immune transition in parenchymal neurosyphilis-authors' reply. | QJM | 2026 | 41329476 | PubTator, text mining | PubMed |
| Reevaluating CV2/CRMP5 positivity as a marker of immune transition in parenchymal neurosyphilis. | QJM | 2026 | 41329475 | PubTator, text mining | PubMed |
| Anti-Yo antibody associated axial movement disorders - a novel phenotype in ANNS. | Immunol Lett | 2026 | 41207392 | PubTator, text mining | PubMed |
| CV2/CRMP5 antibodies are specifically associated with parenchymal neurosyphilis: a retrospective cohort study. | QJM | 2026 | 41123291 | PubTator, text mining | PubMed |
| Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With Tumor Recurrence During Atezolizumab Therapy. | Cureus | 2025 | 41542009 | PubTator, text mining | PubMed |
| Lambert-Eaton myasthenic syndrome presenting with occult mediastinal small cell carcinoma and positivity for anti-CV2/CRMP5 and anti-SOX1 antibodies: a case report. | BMC Neurol | 2025 | 41291493 | PubTator, text mining | PubMed |
| Diagnostic Yield of Anti-Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis. | Eur J Neurol | 2025 | 41074474 | PubTator, text mining | PubMed |
| Unraveling Dual Cognitive Disorders: A Case Report and Literature Review on Marchiafava-Bignami Disease and Possible Alzheimer's Disease. | Diseases | 2025 | 41002746 | PubTator, text mining | PubMed |
| Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy. | Eur J Neurol | 2025 | 40984777 | PubTator, text mining | PubMed |
| Opsoclonus-myoclonus-ataxia Syndrome in an ART-naïve Patient With CSF/Plasma HIV-1 RNA Discordance. | Open Forum Infect Dis | 2025 | 40980571 | PubTator, text mining | PubMed |
| Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. | Arterioscler Thromb Vasc Biol | 2025 | 40964716 | PubTator, text mining | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders. | J Neurochem | 2025 | 40823742 | PubTator, text mining | PubMed |
| Acupuncture for benign prostatic hyperplasia in the elderly: A systematic review of acupoints. | Medicine (Baltimore) | 2025 | 40797416 | PubTator, text mining | PubMed |
| Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats. | Nat Commun | 2025 | 40775229 | PubTator, text mining | PubMed |
| Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report. | BMC Neurol | 2025 | 40760473 | PubTator, text mining | PubMed |
| Pilot study of cerebrospinal fluid biomarkers reveals inflammatory changes in patients with paranoid schizophrenia. | Sci Rep | 2025 | 40754554 | PubTator, text mining | PubMed |
| Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid. | Brain Behav Immun Health | 2025 | 40746968 | PubTator, text mining | PubMed |
| FLAIR hyperintense cortical lesions in myelin oligodendrocyte glycoprotein-associated encephalitis with seizures in children: a retrospective single-center case series. | Front Immunol | 2025 | 40740785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/168667/papers?page=2